1,832
Views
52
CrossRef citations to date
0
Altmetric
Original Articles

Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation

, , , , , , , & show all
Pages 569-580 | Received 02 Nov 2016, Accepted 08 Feb 2017, Published online: 07 Mar 2017

References

  • Aktas B, Kasimir-Bauer S, Wimberger P, Kimmig R, Heubner M. 2013. Utility of mesothelin, L1CAM and afamin as biomarkers in primary ovarian cancer. Anticancer Res. 33:329–336.
  • Al-Nedawi K, Meehan B, Rak J. 2009. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 8:2014–2018.
  • Amundson SA, Do KT, Shahab S, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. 2000. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res. 154:342–346.
  • Arscott WT, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, Zhang G, Tofilon PJ, Camphausen KA. 2013. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Translat Oncol. 16:638–648.
  • Bastos-Amador P, Royo F, Gonzalez E, Conde-Vancells J, Palomo-Diez L, Borras FE, Falcon-Perez JM. 2012. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J Proteomics. 2775:3574–3584.
  • Becerra SP, Notario V. 2013. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev Cancer. 13:258–271.
  • Budworth H, Snijders AM, Marchetti F, Mannion B, Bhatnagar S, Kwoh E, Tan Y, Wang SX, Blakely WF, Coleman M, et al. 2012. DNA repair and cell cycle biomarkers of radiation exposure and inflammation stress in human blood. PLoS One. 7:e48619.
  • Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. 2005. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 17:879–887.
  • Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B. 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 247:163–174.
  • Dang TM, Wong WC, Ong SM, Li P, Lum J, Chen J, Poidinger M, Zolezzi F, Wong SC. 2015. MicroRNA expression profiling of human blood monocyte subsets highlights functional differences. Immunology. 145:404–416.
  • De Toro J, Herschlik L, Waldner C, Mongini C. 2015. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 6:203. Epub 2015/05/23.
  • Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L, Buchner H, Stieber P. 2009. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol, Biomark Prevent. 18:1127–1133.
  • Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pasa-Tolic L, Jenster G. 2013. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS One. 8:e82589.
  • Gong M, Ma J, Li M, Zhou M, Hock JM, Yu X. 2012. MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro Oncol. 14:1007–1017.
  • Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR. 2009. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res. 8:1304–1314.
  • Guo F, Tian J, Lin Y, Jin Y, Wang L, Cui M. 2013. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. J Int Med Res. 41:1456–1461.
  • Hauck SM, Dietter J, Kramer RL, Hofmaier F, Zipplies JK, Amann B, Feuchtinger A, Deeg CA, Ueffing M. 2010. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Molec Cellular Proteomics. 9:2292–2305.
  • Hui E, Yeung CY, Lee PC, Woo YC, Fong CH, Chow WS, Xu A, Lam KS. 2014. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes. J Clin Endocrinol Metab. 99:E2169–2177.
  • Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et al. 2012. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One. 7:e52397.
  • Jackson D, Craven RA, Hutson RC, Graze I, Lueth P, Tonge RP, Hartley JL, Nickson JA, Rayner SJ, Johnston C, et al. 2007. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin Cancer Res. 13:7370–7379.
  • Jelonek K, Wojakowska A, Marczak L, Muer A, Tinhofer-Keilholz I, Lysek-Gladysinska M, Widlak P, Pietrowska M. 2015. Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma. Acta Biochim Pol. 62:265–272.
  • Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, Hulett MD, Mathivanan S. 2013. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 13:3354–3364.
  • Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borras FE, Breakefield X, Budnik V, et al. 2012. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10:e1001450.
  • Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S. 2015. Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. Oncotarget. 6:15375–15396.
  • Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, et al. 2015. EVpedia: a community web portal for extracellular vesicles research. Bioinformatics. 31:933–939.
  • Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Yang HD, Park M, Park WS, et al. 2015. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget. 6:8089–8102.
  • Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB. 2002. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 270:211–226.
  • Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. 2011. Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 52:2999–3007.
  • Li M, Zeringer E, Barta T, Schageman J, Cheng A, Vlassov AV. 2014. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philosoph Transact Royal Soc London Series B, Biolog Sci. 369:1652–1659.
  • Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, Xu YM, Huang LF, Wang XZ. 2015. Exosomes: novel biomarkers for clinical diagnosis. Scientific World J. 2015:657086
  • Lu M, Shi B, Wang J, Cao Q, Cui Q. 2010. TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics. 11:419
  • Lynam-Lennon N, Reynolds JV, Marignol L, Sheils OM, Pidgeon GP, Maher SG. 2012. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J Mol Med. 90:1449–1458.
  • Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. 2012. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40:D1241–1244.
  • Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ. 2010. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Molec Cellular Proteomics. 9:197–208.
  • Mayburd AL, Martlinez A, Sackett D, Liu H, Shih J, Tauler J, Avis I, Mulshine JL. 2006. Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin Cancer Res. 12:1820–1827.
  • McKenzie AJ, Hoshino D, Hong NH, Cha DJ, Franklin JL, Coffey RJ, Patton JG, Weaver AM. 2016. KRAS-MEK signaling controls Ago2 sorting into exosomes. Cell Rep. 15:978–987.
  • Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 133:217–222.
  • Merl J, Ueffing M, Hauck SM, von Toerne C. 2012. Direct comparison of MS-based label-free and SILAC quantitative proteome profiling strategies in primary retinal Müller cells. Proteomics. 12:1902–1911.
  • Meyer SU, Pfaffl MW, Ulbrich SE. 2010. Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity? Biotechnol Lett. 32:1777–1788.
  • Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. 2016. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 44:D336–342.
  • Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, Kohn EC. 2012. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 15:33–45.
  • Molin S, Merl J, Dietrich KA, Regauer M, Flaig M, Letule V, Saucke T, Herzinger T, Ruzicka T, Hauck SM. 2015. The hand eczema proteome: imbalance of epidermal barrier proteins. Br J Dermatol. 172:994–1001.
  • Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A. 2009. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 100:1603–1607.
  • O’Leary VB, Ovsepian SV, Carrascosa LG, Buske FA, Radulovic V, Niyazi M, Moertl S, Trau M, Atkinson MJ, Anastasov N. 2015. PARTICLE, a triplex-forming long ncRNA, regulates locus-specific methylation in response to low-dose irradiation. Cell Rep. 11:474–485.
  • Okudela K, Suzuki T, Umeda S, Tateishi Y, Mitsui H, Miyagi Y, Ohashi K. 2014. A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis. Oncol Rep. 32:1374–1384.
  • Paul S, Barker CA, Turner HC, McLane A, Wolden SL, Amundson SA. 2011. Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures. Radiat Res. 175:257–265.
  • Raj DA, Fiume I, Capasso G, Pocsfalvi G. 2012. A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int. 81:1263–1272.
  • Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ. 2006. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 20:847–856.
  • Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, Battistelli C, Alonzi T, Weisz A, Tripodi M. 2016. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Reports. 17:799–808.
  • Schwertman P, Bekker-Jensen S, Mailand N. 2016. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat Rev Mol Cell Biol. 17:379–394.
  • Seeber B, Morandell E, Lunger F, Wildt L, Dieplinger H. 2014. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol. 12:88.
  • Simpson RJ, Jensen SS, Lim JW. 2008. Proteomic profiling of exosomes: current perspectives. Proteomics. 8:4083–4099.
  • Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. 2008. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 10:1470–1476.
  • Sonkoly E, Stahle M, Pivarcsi A. 2008. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 18:131–140.
  • Squadrito ML, Baer C, Burdet F, Maderna C, Gilfillan GD, Lyle R, Ibberson M, De Palma M. 2014. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 8:1432–1446.
  • Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, Atkinson MJ, Belka C, Moertl S, Zitzelsberger H. 2013. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol. 8:296
  • Taylor DD, Gercel-Taylor C. 2008. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 110:13–21.
  • Théry C, Amigorena S, Raposo G, Clayton A. 2006. Unit 3.22: Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 3:3.22.1–3.22.29. doi: 10.1002/0471143030.cb0322s30
  • Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B. 2006. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 34:W645–650.
  • Thomas SN, Liao Z, Clark D, Chen Y, Samadani R, Mao L, Ann DK, Baulch JE, Shapiro P, Yang AJ. 2013. Exosomal proteome profiling: a potential multi-marker cellular phenotyping tool to characterize hypoxia-induced radiation resistance in breast cancer. Proteomes. 1:87–108.
  • Turchinovich A, Weiz L, Langheinz A, Burwinkel B. 2011. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39:7223–7233.
  • Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. 2013. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 32:2747–2755.
  • Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659.
  • Villarroya-Beltri C, Baixauli F, Gutierrez-Vazquez C, Sanchez-Madrid F, Mittelbrunn M. 2014. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 28:3–13.
  • Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sanchez-Madrid F. 2013. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Comms. 4:2980.
  • Wang J, Huang SK, Zhao M, Yang M, Zhong JL, Gu YY, Peng H, Che YQ, Huang CZ. 2014. Identification of a circulating microRNA signature for colorectal cancer detection. PLoS One. 9:e87451
  • Widlak P, Jelonek K, Wojakowska A, Pietrowska M, Polanska J, Marczak L, Miszczyk L, Skladowski K. 2015. Serum proteome signature of radiation response: upregulation of inflammation-related factors and downregulation of apolipoproteins and coagulation factors in cancer patients treated with radiation therapy – a pilot study. Int J Radiat Oncol Biol Phys. 92:1108–1115.
  • Wisniewski JR, Zougman A, Nagaraj N, Mann M. 2009. Universal sample preparation method for proteome analysis. Nat Methods. 6:359–362.
  • Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, et al. 2015. Biological properties of extracellular vesicles and their physiological functions. J Extracellular Vesicles. 4:27066.
  • Yang X, Zeng Z, Hou Y, Yuan T, Gao C, Jia W, Yi X, Liu M. 2014. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. PLoS One. 9:e88745
  • Yentrapalli R, Azimzadeh O, Kraemer A, Malinowsky K, Sarioglu H, Becker KF, Atkinson MJ, Moertl S, Tapio S. 2015. Quantitative and integrated proteome and microRNA analysis of endothelial replicative senescence. J Proteomics. 126:12–23.
  • Yu X, Harris SL, Levine AJ. 2006. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66:4795–4801.
  • Yuana Y, Sturk A, Nieuwland R. 2013. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 27:31–39.
  • Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S. 2015. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 13:17–24.
  • Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. 2015. Exosomes in cancer: small particle, big player. J Hematol Oncol. 8:83
  • Zhou M, Lucas DA, Chan KC, Issaq HJ, Petricoin EF III, Liotta LA, Veenstra TD, Conrads TP. 2004. An investigation into the human serum ‘interactome’. Electrophoresis. 25:1289–1298.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.